Temporary corneal repair (TCR) program, and will support food and drug administration (FDA) clearance/approval of a temporary, non-surgical solution to close open globe, full thickness corneal wounds.…

Ended Definitive Contract Awarded Last action

Contract number
W81XWH18C0180
Awardee
Awarding agency
Obligated
$4,249,654

Award facts

Opportunity
Contract value 100% obligated
$4,249,654.44 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Redwood City, CA 94065, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00011 · Phase 2: animal study -$36,849
Supplemental Agreement for work within scope P00010 · Amend the SOW. $0
Supplemental Agreement for work within scope P00009 · Phase 2: animal study - novel product for temporary corneal repair adding additional studies per FDA requirements. $48,091
Supplemental Agreement for work within scope P00008 $676,979
Other Administrative Action P00007 · Phase 2: animal study $0
Supplemental Agreement for work within scope P00006 · Modification to amend the statement of work and add additional LOE to the award due to a design change in the R & D product for this award. $899,000
Funding Only Action P00005 $67,155
Other Administrative Action P00004 · Phase 2: animal study $0
Other Administrative Action P00003 · MOD; P00003 for 18-C-0180 that is applying an administrative change to the wawf instructions and the shipping address dodaac in the award. $0
Supplemental Agreement for work within scope P00002 · MOD to change contract type for clins 0001 and 0002 (phase I and phase II) of the TCR contract. Adding incremental funding to clin 0002 and updating the… $617,000
Supplemental Agreement for work within scope P00001 · TCR; MOD to add in progress payments, amend delivery dates in SOW, increase ceiling on clin 0002, and add in various clauses to $0
Original award $1,978,278
Show all 12

About this award

Written by GovTribe AI ·

The Department of the Army Medical Command awarded a definitive cost-no-fee contract to Ashvattha Therapeutics, LLC, a for-profit limited liability company, to support the Temporary Corneal Repair (TCR) program and the Food and Drug Administration (FDA) clearance/approval of a temporary, non-surgical solution to close open globe, full thickness corneal wounds. The contract, valued at $4,249,654.44, requires the vendor to engage the FDA and conduct Good Laboratory Practice (GLP) animal studies, as well as deliver prototype devices to the government. This contract award is not associated with a set-aside program.

Description

As the agency reported it.

Temporary corneal repair (TCR) program, and will support food and drug administration (FDA) clearance/approval of a temporary, non-surgical solution to close open globe, full thickness corneal wounds. This specific contract action is for potential developers to engage the FDA, conduct GLP animal studies, and deliver prototype devices to the government.

Quick answers

Who was awarded contract W81XWH18C0180?

W81XWH18C0180 was awarded to Ashvattha Therapeutics, LLC by Medical Command (Department of the Army) on September 24, 2018.

How much is contract W81XWH18C0180 worth?

The government has obligated $4,249,654 on W81XWH18C0180.

Was contract W81XWH18C0180 competed?

The extent of competition for W81XWH18C0180 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login